William H. Moore
YOU?
Author Swipe
View article: Safety and feasibility of percutaneous pulsed electrical field ablation in multiple organs: A multi-center retrospective study☆
Safety and feasibility of percutaneous pulsed electrical field ablation in multiple organs: A multi-center retrospective study☆ Open
Percutaneous PEF is feasible to be performed across a variety of organs. Although difficult to compare with other modalities, this data suggests that PEF ablation is relatively safe. However, further prospective studies with larger sample …
View article: Supplementary Table S15 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S15 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S15: Correlation test for the identified components integrated by microbiome and transcriptome
View article: Supplementary Table S16 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S16 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S16: Absolute loadings for the identified components integrated by microbiome (ASV) and transcriptome (genes annotated to pathways) in unaffected lung samples with recurrence
View article: Supplementary Table S12 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S12 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S12: IPA analysis showing canonical pathways based on differentially expressed genes compared between recurrence and no recurrence groups, in tumor and unaffected lung samples. Scores are based on z-score
View article: Supplementary figure S2 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary figure S2 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Figure S2 shows Bacterial analysis across sample types
View article: Supplementary Table S14 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S14 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S14: Loadings of ASVs and genes for the first two component identified by sparse CCA analysis
View article: Supplementary Table S2 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S2 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S2: Taxonomic differential abundance between tumor and lung samples
View article: Supplementary Table S6 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S6 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S6: Taxonomic differential abundance between recurrence and non-recurrence lung samples
View article: Supplementary Table S18 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S18 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S18: Absolute loadings for the identified components integrated by microbiome (ASV) and transcriptome (genes annotated to pathways) in tumor samples with recurrence
View article: Supplementary figure S4 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary figure S4 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Figure S4 shows Identification of top taxa found in background samples as compared with lower airway tissue samples
View article: Supplementary Table S19 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S19 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S19: Absolute loadings for the identified components integrated by microbiome (ASV) and transcriptome (genes annotated to pathways) in tumor samples without recurrence
View article: Supplementary Table S3 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S3 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S3: COX proportional hazards values for alpha diversity measures associated with time to recurrence
View article: Supplementary Table S11 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S11 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S11: Genomic differential abundance between recurrence and no recurrence lung samples
View article: Supplementary Table S4 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S4 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S4: MIRKAT analyses for beta diversity measures associated with time to recurrence
View article: Supplementary Table S5 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S5 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S5: Taxonomic differential abundance between recurrence and non-recurrence tumor samples
View article: Supplementary Table S13 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S13 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S13: Cibersort analysis results showing differences between sample type and recurrence groups
View article: Data from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Data from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Background:Risk of early-stage lung adenocarcinoma recurrence after surgical resection is significant, and the postrecurrence median survival is approximately 2 years. Currently, there are no commercially available biomarkers that predict …
View article: Supplementary Table S8 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S8 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S8: COX-PH model results of microbial profile association with time and recurrence
View article: Supplementary Table S7 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S7 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S7: Gini indices for taxa when recurrence was evaluated using a random forest classifier for different percentages of total taxa
View article: Supplementary figure S7 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary figure S7 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Figure S7 shows Cibersort data
View article: Supplementary Table S10 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S10 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S10: Genomic differential abundance between recurrence and no recurrence tumor samples
View article: Supplementary Table S1 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S1 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S1: identification of possible contaminants
View article: Supplementary figure S6 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary figure S6 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Figure S6 shows Alpha diversity measurement in clinical outcome groups across different sample types.
View article: Supplementary Table S17 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S17 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S17: Absolute loadings for the identified components integrated by microbiome (ASV) and transcriptome (genes annotated to pathways) in unaffected lung samples without recurrence
View article: Supplementary figure S3 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary figure S3 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Figure S3 shows Alpha and Beta diversity among different baseline characteristic
View article: Supplementary Table S9 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary Table S9 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Table S9: Genomic differential abundance between tumor and lung samples
View article: Supplementary figure S1 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary figure S1 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Figure S1 shows Bacterial load
View article: Supplementary figure S5 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Supplementary figure S5 from Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Supplementary Figure S5 shows Differential expression of taxa between tumor and unaffected lung samples.
View article: Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma Open
Background: Risk of early-stage lung adenocarcinoma recurrence after surgical resection is significant, and the postrecurrence median survival is approximately 2 years. Currently, there are no commercially available biomarkers that predict…
View article: A Rare Case of a Heterotopic Sacrococcygeal Glial Nodule
A Rare Case of a Heterotopic Sacrococcygeal Glial Nodule Open
Heterotopic glial nodule is a rare congenital non-neoplastic lesion that is characterized by ectopic brain tissue. It has occasionally been reported to affect areas such as the nose and face. The report presents a rare case of sacrococcyge…